Literature DB >> 10714983

Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition.

D Alland1, A J Steyn, T Weisbrod, K Aldrich, W R Jacobs.   

Abstract

The cell wall provides an attractive target for antibiotics against Mycobacterium tuberculosis. Agents such as isoniazid and ethambutol that work by inhibiting cell wall biosynthesis are among the most highly effective antibiotics against this pathogen. Although considerable progress has been made identifying the targets for cell wall active antibiotics, little is known about the intracellular mechanisms that are activated as a consequence of cell wall injury. These mechanisms are likely to have an important role in growth regulation and in the induction of cell death by antibiotics. We previously discovered three isoniazid-induced genes (iniB, iniA, and iniC) organized in tandem on the M. tuberculosis genome. Here, we investigate the unique features of the putative iniBAC promoter. This promoter was specifically induced by a broad range of inhibitors of cell wall biosynthesis but was not inducible by other conditions that are toxic to mycobacteria via other mechanisms. Induction required inhibitory concentrations of antibiotics and could be detected only in actively growing cells. Analysis of the iniBAC promoter sequence revealed both a regulatory element upstream and a potential repressor binding region downstream of the transcriptional start site. The induction phenotype and structure of the iniBAC promoter suggest that a complex intracellular response occurs when cell wall biosynthesis is inhibited in M. tuberculosis and other mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714983      PMCID: PMC101861          DOI: 10.1128/JB.182.7.1802-1811.2000

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

Review 1.  Mycobacterial promoters.

Authors:  M A Mulder; H Zappe; L M Steyn
Journal:  Tuber Lung Dis       Date:  1997

2.  Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

Authors:  A Tomasz; A Albino; E Zanati
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

4.  The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

Authors:  M Arthur; C Molinas; P Courvalin
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

5.  Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.

Authors:  S B Snapper; R E Melton; S Mustafa; T Kieser; W R Jacobs
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

6.  An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection.

Authors:  M A Fischl; R B Uttamchandani; G L Daikos; R B Poblete; J N Moreno; R R Reyes; A M Boota; L M Thompson; T J Cleary; S Lai
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

7.  Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus.

Authors:  G K Best; N H Best; A V Koval
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

9.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

10.  Estimates of future global tuberculosis morbidity and mortality.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-12-17       Impact factor: 17.586

View more
  63 in total

Review 1.  The chemical biology of new drugs in the development for tuberculosis.

Authors:  Clifton E Barry; John S Blanchard
Journal:  Curr Opin Chem Biol       Date:  2010-05-07       Impact factor: 8.822

2.  Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.

Authors:  Min Zhang; Jun Yue; Yan-Ping Yang; Hong-Mei Zhang; Jian-Qiang Lei; Rui-Liang Jin; Xue-Lian Zhang; Hong-Hai Wang
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 3.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds.

Authors:  Vandana Singh; Rajesh Kumar Biswas; Bhupendra N Singh
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

5.  High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

Authors:  Subramaniam Ananthan; Ellen R Faaleolea; Robert C Goldman; Judith V Hobrath; Cecil D Kwong; Barbara E Laughon; Joseph A Maddry; Alka Mehta; Lynn Rasmussen; Robert C Reynolds; John A Secrist; Nice Shindo; Dustin N Showe; Melinda I Sosa; William J Suling; E Lucile White
Journal:  Tuberculosis (Edinb)       Date:  2009-09-15       Impact factor: 3.131

Review 6.  Roles of two-component regulatory systems in antibiotic resistance.

Authors:  Aimee Rp Tierney; Philip N Rather
Journal:  Future Microbiol       Date:  2019-05-08       Impact factor: 3.165

Review 7.  Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

Authors:  Katherine A Sacksteder; Marina Protopopova; Clifton E Barry; Koen Andries; Carol A Nacy
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

8.  Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.

Authors:  Krupa Naran; Atica Moosa; Clifton E Barry; Helena I M Boshoff; Valerie Mizrahi; Digby F Warner
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

9.  The characterization of conserved binding motifs and potential target genes for M. tuberculosis MtrAB reveals a link between the two-component system and the drug resistance of M. smegmatis.

Authors:  Yuqing Li; Jumei Zeng; Hua Zhang; Zheng-Guo He
Journal:  BMC Microbiol       Date:  2010-09-16       Impact factor: 3.605

10.  Identification of two Mycobacterium smegmatis lipoproteins exported by a SecA2-dependent pathway.

Authors:  Henry S Gibbons; Frank Wolschendorf; Michelle Abshire; Michael Niederweis; Miriam Braunstein
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.